Microbiome-driven alterations in tryptophan metabolism contribute to behavioral comorbidities in the Muc2 knockout mouse model of chronic colitis
Jessica K Josephson, Jacqueline A Barnett, Emad Yuzbashian, Andrea Verdugo-Meza, Susan J Murch, Tyler J Wenzel, Andis Klegeris, Keith A Sharkey, Deanna L Gibson · 2026
Read Microbiome-driven alterations in tryptophan metabolism contribute to behavioral comorbidities in the Muc2 knockout mouse model of chronic colitis by Jessica K Josephson, Jacqueline A Barnett, Emad Yuzbashian, Andrea Verdugo-Meza, Susan J Murch, Tyler J Wenzel, Andis Klegeris, Keith A Sharkey, Deanna L Gibson (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13313184.txt.
Description
Jessica K Josephson and co-workers examine gut and brain links in chronic bowel disease in a 2026 study. They note that inflammatory bowel disease keeps rising and often comes with anxiety, low mood, and memory loss, yet the paths that join gut illness to these brain effects stay unclear.
Their test used Muc2 knockout mice, a model of lasting colitis, raised with or without gut microbes, plus normal mice for contrast. The mice were checked for anxious and low-mood behavior and for memory faults. The team also measured tryptophan and its breakdown products in colon, blood, and brain, and looked at the blood-brain barrier. The design lets them ask whether microbe-driven shifts in tryptophan use track with the behavior changes seen in colitis.
Catalog record
| CREATOR | Jessica K Josephson, Jacqueline A Barnett, Emad Yuzbashian, Andrea Verdugo-Meza, Susan J Murch, Tyler J Wenzel, Andis Klegeris, Keith A Sharkey, Deanna L Gibson |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 63083 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |